Clinical Trials Directory

Trials / Completed

CompletedNCT01162018

Acupuncture for Sleep Disruption in Cancer Survivors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
65 (actual)
Sponsor
Stanford University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The proposed study will recruit 60 women with breast cancer who finished undergoing treatment who complain of persistent insomnia problems that began with onset of their cancer diagnosis. The eligible women would be randomized and stratified by sleep problems to two arms: (Acupuncture Arm vs. Sham Acupuncture) with a goal of having 48 patients complete the study (we anticipate about 20% attrition rate). The study interventions will begin after patients completed their treatment. The placebo control for acupuncture will be a validated sham acupuncture control Assessments will be made with daily diaries and with weekly questionnaires. PSG data will be collected on the subsample of the population. Data will be gathered via pencil-and-paper measures before, during, immediately following, one month following the completion of treatment and six months after the conclusion of treatment. In addition, actigraphy data (objective sleep continuity data) will be acquired prior to and following treatment

Conditions

Interventions

TypeNameDescription
PROCEDUREacupunctureThe eligible women would be randomized and stratified by sleep problems to two arms: (Acupuncture Arm vs. Sham Acupuncture) with a goal of having 48 patients complete the study (we anticipate about 20% attrition rate). The study interventions will begin after patients completed their treatment. The placebo control for acupuncture will be a validated sham acupuncture control Assessments will be made with daily diaries and with weekly questionnaires. There are ten sessions each lasting approximately 20 minutes. All participants will have PSG data collected.
OTHERplacebo

Timeline

Start date
2011-02-01
Primary completion
2012-07-01
Completion
2012-08-01
First posted
2010-07-14
Last updated
2019-04-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01162018. Inclusion in this directory is not an endorsement.